The cell culture media sera and reagents market is expected to reach USD 7.2 billion by 2026, growing at a CAGR of 8.1% from 2021 to 2026. This growth is being driven by a number of factors, including the surging demand for medical supplies to care for the infected population, rising clinical trials, and growing funds for R&D activities.
Market Drivers
The cell culture media, sera, and reagents market is driven by a host of factors, some of which are noted below:
• Surging demand for medical supplies: The COVID-19 pandemic has resulted in a strong surge in demand for medical supplies, including cell culture media, sera, and reagents. This is due to the need for these products to develop and manufacture vaccines and treatments for the virus.
• Rising clinical trials: The number of clinical trials is increasing, which is creating a demand for cell culture media, sera, and reagents. These products are used to grow and maintain cells in laboratory settings, which is essential for conducting clinical trials.
• Growing funds for R&D activities: Governments and private companies are investing increasing amounts of money in research and development (R&D) activities. This is leading to the development of new and innovative cell culture products, which is further driving market growth.
Regional Analysis
North America is expected to hold the largest share of the cell culture media, sera, and reagents market during the forecast period. This is due to the presence of a large number of product manufacturers, a rising aging population, and well-established healthcare infrastructure. Europe is expected to be the second-largest market, followed by Asia Pacific.
Key Players
Some of the key players in the cell culture media, sera, and reagents market include:
• Becton Dickinson (US)
• Corning (US)
• EMD Millipore (US)
• GE Healthcare (US)
• Lonza (Switzerland)
• PromoCell (Germany)
• Sigma-Aldrich (US)
• Thermo Fisher (US)
• VWR (US)
• Wheaton (US)
COVID-19 Impact
The COVID-19 pandemic has had a positive impact on the cell culture media, sera, and reagents market. The pandemic has resulted in a strong surge in demand for medical supplies, including cell culture media, sera, and reagents. This is due to the need for these products to develop and manufacture vaccines and treatments for the virus.
Conclusion
The cell culture media, sera, and reagents market is expected to grow at a healthy CAGR over the next few years. This growth is being driven by a number of factors, including the surging demand for medical supplies, rising clinical trials, and growing funds for R&D activities. North America is expected to hold the largest share of the market, followed by Europe and Asia Pacific.